New Legal Pathway for Biosimilars Creates Opportunities and Challenges For Biological Manufacturers — A Guide To The Legislation
14 June 2010
Foley Partners Jacqueline Wright Bonilla and Nathan Beaver authored an article that appeared in the June 2010 issue of Bloomberg’s Health Law Report titled “New Legal Pathway for Biosimilars Creates Opportunities and Challenges For Biological Manufacturers — A Guide To The Legislation.”
Author(s)
Related Insights
24 July 2024
Events
Bitcoin 2024: Legal Aspects of Bitcoin Mining and Contracts
As part of the Bitcoin 2024 conference, Chanley Howell (Partner, Jacksonville) will be joining the panel Legal Aspects of Bitcoin Mining and Contracts.
03 July 2024
Viewpoints
The End of Chevron Deference and the Implications for the SEC
On June 28, 2024, the U.S. Supreme Court issued its decision in Loper Bright Enterprises v. Raimondo and Relentless Inc. v. Department of Commerce, overruling the Chevron doctrine.
03 July 2024
Viewpoints
Five Compliance Best Practices Every Multinational Company Should Consider for … Tailoring Compliance Policies and Internal Controls for Local Countries
Tailoring compliance policies to local countries is crucial for ensuring that organizational practices align with specific legal, cultural, and regulatory requirements in each jurisdiction where the organization operates.